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1. Introduction 
Embryo transfer refers to a step in the process of assisted reproduction in which one or 
several embryos are placed into the uterus of a female with the intent to establish a 
pregnancy. Currently this biotechnology has become one of the prominent high businesses 
worldwide. This technique, which is often used in connection with in vitro fertilization (IVF), 
has widely been used in animals or human, in which situations the goals may vary. In 
animal husbandry, embryo transfer has become the most powerful tool for animal scientists 
and breeders to improve genetic construction of their animal herds and increase quickly 
elite animal numbers which have recently gained considerable popularity with seedstock 
dairy and beef producers. In human, embryo transfer technique has mainly been used for 
the treatment of infertile couples to realize their dream to have their children. The history of 
the embryo transfer procedure goes back considerably farther, but the most modern 
applicable embryo transfer technology was developed in the 1970s (Steptoe and Edwards, 
1978). In the last three decades, embryo transfer has developed into a specific advanced 
biotechnology which has gone through three major changes, “three generations”---the first 
with embryo derived from donors (in vivo) by superovulation, non-surgical recovery and 
transfer, especially in cattle embryos, the second with in vitro embryo production by ovum 
pick up with in vitro fertilization (OPU-IVF) and the third including further in vitro 
developed techniques, especially innovated embryo micromanipulation technique, which 
can promote us to perform embryo cloning involved somatic cells and embryonic stem cells, 
preimplantation genetic diagnosis (PGD), transgenic animal production etc. At the same 
time, commercial animal embryo transfer has become a large international business 
(Betteridge, 2006), while human embryo transfer has spread all over the world for infertility 
treatment. Just only in the United States of America there are 442 assisted reproductive 
technology (ART) centers with IVF programs in 2009 report of the Centers for Disease 
Control and Prevention. Embryo transfer, besides male sperm, involves entire all process 
from female ovarian stimulation (start) to uterine receptivity (end). During this entire 
process, many new bio-techniques have been developed (Figure 1). These techniques 
include optimal ovarian stimulation scheme, oocyte picking up (OPU) or oocyte retrieval, in 
vitro maturation (IVM) of immature oocytes, in vitro fertilization (IVF) and intracytoplasmic 
sperm injection (ICSI), preimplantation genetic diagnosis (PGD), blastocyst embryo culture 
technology, identification of optimal uterine environment etc. Here, we will review some 
key newly developed biotechnologies on human embryo transfer. 
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Fig. 1. Schematic representation of main embryo biotechnologies which can involve from 
ovary to uterus. 
2. Ovarian stimulation technique 
So far we have known that female ovary at birth has about 2 million primordial follicles 
with primary oocytes and at puberty ovary has 300,000 to 400,000 oocytes. From puberty, 
oocytes start frequently to grow, mature and ovulate from ovaries under endocrine 
hormone stimulation, such as follicle stimulating hormone (FSH), luteinizing hormone (LH) 
and estradiol, but normal fertile woman usually ovulate only an oocyte per menstrual cycle. 
This will ensure women to be able to have a normal single baby pregnancy. However, in an 
attempt to compensate for inefficiencies in IVF procedures, patients need to undergo 
ovarian stimulation using high doses of exogenous gonadotrophins to allow retrieval of 
multiple oocytes in a single cycle. Current IVF stimulation protocols in the United State 
generally involve the use of 3 types of drugs: 1) a medication to suppress the LH surge and 
ovulation until the developing eggs are ready, GnRH-agonist (gonadotropin releasing 
hormone agonist) such as Lupron and GnRH-antagonist such as Ganirelix or Cetrotide; 2) 
FSH product (follicle stimulating hormone) to stimulate development of multiple eggs such 
as Gonal-F, Follistim, Bravelle, Menopur; 3) HCG (human chorionic gonadotropin) to cause 
final maturation of the eggs. The use of such ovarian stimulation protocols enables the 
selection of one or more embryos for transfer, while supernumerary embryos can be 
cryopreserved for transfer in a later cycle (Macklon et al. 2006). Currently the standard 
regimen procedures for ovarian stimulation have been set up in all IVF centers (Santos, et 
al., 2010) in which almost centers use exogenous gonadotrophins as routine procedure to 
stimulate patients’ ovaries to obtain multiple eggs. This technique works very well in most 
patients. Thus, this leads to setting up many drug companies to produce all kind of 
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stimulation drugs for human assisted reproductive technology (ART). However, evidences 
of recent several year studies have showed that ovarian stimulation may itself have 
detrimental effects on oogenesis, embryo quality, uterus endometrial receptivity and 
perhaps perinatal outcomes. The retrieval oocyte number is also considered to be an 
important prognostic variable in our routine IVF practice (see Chapter 3 in this book). Also, 
if this stimulation scheme produces too many eggs, it often results in hyperstimulation 
syndrome. Standard IVF requires the administration of higher dosages of injectable 
medications to stimulate the growth of multiple eggs. These medications are expensive and are 
associated with certain potential health risks. Careful monitoring must be performed to ensure 
safety and efficacy. While these factors lead to increased costs and time commitment for the 
patient, the result is an increased number of embryos available for transfer. Additionally, in 
standard or traditional IVF, cryopreservation of surplus embryos for transfer in a non-
stimulated cycle may be available. The overall expected take-home baby rate with standard 
IVF varies considerably, based primarily upon the patient’s age. Recently some IVF centers 
have begun to use natural or minimal stimulation on IVF and obtained good results.  
The recent popularity of Mini-IVF (minimal stimulation IVF), Micro-IVF, natural cycle for 
IVF, oocyte in vitro maturation (IVM) has attested to the changes taking place in the practice 
of advanced reproductive technologies (Edward, 2007). This technique has some advantage 
and has good future use. A common feature all of these procedures share is the use of less 
infertility medications. The reduction in medication use compared to a normal IVF cycle 
ranges from a 50% to a 100% reduction. If the less medication is used, the less monitoring is 
required (blood test and ultrasounds). The amount of reduction in monitoring depends on 
the procedure being done and the philosophy of the practice. For most of these approaches, 
fewer eggs are involved, which may mean there is less work for the laboratory to do. Some 
programs will discount their routine laboratory charges compared to regular IVF and 
patients may pay less expense (see Chapter 2). Also, the most significant risk of routine IVF, 
severe ovarian hyperstimulation syndrome, could be decreased in all of these procedures or 
completely eliminated in some pure natural IVF cycles and programmed IVM cycles (Tang-
Pedersen et al., 2012). This can be very important for some women with severe polycystic 
ovary syndrome (PCOS) who are at increased risk for significant discomfort or even (rarely) 
hospitalization with routine IVF approaches. However, this technique needs more times of 
oocyte retrieval and results in a lower pregnancy rate per egg retrieval cycle because only one 
or a very few eggs may be retrieved per cycle. Thus, this technique may be used in some 
specific woman populations, such as younger women less than 30 years old or aged women 
over 40 years old. In this book, the impact of ovarian stimulation and underlying mechanisms 
will be reviewed and some strategies for reducing the impact of ovarian stimulation on IVF 
outcomes are also addressed. (Please further read Chapter 2 in this book).  
As describing above, ovarian hyperstimulation syndrome (OHSS) usually occurs as a result 
of taking hormonal medications that stimulate oocyte development in woman’s ovaries. In 
OHSS, the ovaries become swollen and painful and its symptoms can range from mild to 
severe. About one-fourth of women who take injectible fertility drugs get a mild OHSS 
form, which goes away after about a week. If woman becomes pregnant after taking one of 
these fertility drugs, her OHSS may last several weeks. A small proportion of women taking 
fertility drugs develop a more severe OHSS form, which can cause rapid weight gain, 
abdominal pain, vomiting and shortness of breath. In order to prevent OHSS occur, some 
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effective steps should be taken. If the OHSS has happened, specific treatment should be 
guided by the severity of OHSS. The aim of the treatment is to help relieving symptoms and 
prevent complications. Chapter 4 of this book has given a detail review about OHSS 
diagnosis, prevention and treatment. 
3. Advances in insemination and in vitro fertilization technology 
Embryo development begins with fertilization. Prior to fertilization, both the oocytes and 
the sperm must undergo a series of maturational events to acquire their capacity to achieve 
fertilization. Much research in this area has been geared toward improving reproductive 
efficiencies of farm animals and preserving endangered species. An important milestone of 
embryo transfer is in vitro fertilization (IVF). In animals, IVF has offered a very valuable tool 
to study mammalian fertilization and early embryo development. in vitro fertilization is a 
process by which retrieval oocytes fertilized by sperm outside the body, in vitro. IVF is a 
major treatment in infertility when other methods of assisted reproductive technology have 
failed. This technique has become a routine procedure and widely been used in human 
infertile treatment all over the world. IVF was initially created to help those women whose 
fallopian tubes were blocked not allowing for fertilization to occur. Over the years through, 
this technique has become very efficient in achieving pregnancies for several other 
situations including unexplained infertility. So far many infertile couples may obtain their 
dreamed children by IVF technique. However, IVF isn’t just for issues relating to women. 
Male sperm amount and quality has a determined effect on egg fertilization. Sperm 
dysfunction is associated with the inability of sperm to bind and penetrate the oocyte zona 
pellucida. During last two decades, micromanipulation techniques have undergone some 
major developments which include partial zona dissection (PZD), subzonal sperm injection 
(SUZI) and intracytoplasmic sperm injection (ICSI). These methods greatly improve oocyte 
fertilization rate. More importance is that ICSI technique can solve sever male infertility 
problem including 1) complete absence of sperm (azoospermia); 2) low sperm count 
(oligozoospermia); 3) abnormal sperm shape (teratozoospermia); 4) problems with sperm 
movement (asthenozoospermia); 5) completely immobile sperm (necrozoospermia). To 
further review the development of these technologies, four chapters about sperm treatment 
have been listed in this book.  
Firstly, some basic knowledge of sperm physiology has been described and evaluation of 
male infertility has been discussed (Chapter 5). Secondly, the sperm chromosomal 
abnormality has a significant effect on embryo quality and pregnancy rate. Even so it may 
result in a lot of miscarriage after pregnancy. Currently there are many researches about 
sperm abnormality including sperm chromosomal examination, sperm DNA fragmentation 
analysis. Thus, a chapter about meiotic chromosome abnormalities and spermatic FISH in 
infertile patients with normal karyotype has listed (Chapter 6). This chapter indicates that 
the incidence of spermatic aneuploid in the infertile population is as three times as in the 
fertile population and using FISH technique may diagnosis testicular sperm meiosis. This is 
a very interesting result. Thirdly, in the recent years, ICSI technique has experienced a great 
development to intracytoplasmic morphologically-selected sperm injection (IMSI) and a 
method for selection of hyaluronan bound sperm for use in ICSI (PICSI) (Parmegiani et al., 
2010a,b; Said & Land 2011; Berger et al., 2011). These innovations have significantly 
increased egg fertilization and pregnancy rates in many IVF clinics. The major aim of these 
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techniques is to select a normal good spermatozoon without any dysfunction for ICSI to 
obtain a good quality embryo for transfer. Oligozoospermic men often carry seminal 
populations demonstrating increased chromosomal aberrations and compromised DNA 
integrity. Therefore, the in vitro selection of sperm for ICSI is critical and directly influences 
the paternal contribution to preimplantation embryogenesis. Hyaluronan (H), a major 
constituent of the cumulus matrix, may play a critical role in the selection of functionally 
competent sperm during in vivo fertilization (Parmegiani et al., 2010a). Hyaluronan bound 
sperm (HBS) exhibit decreased levels of cytoplasmic inclusions and residual histones, an 
increased expression of the HspA2 chaperone protein and a marked reduction in the 
incidence of chromosomal aneuploidy. The relationship between HBS and enhanced levels of 
developmental competence led to the current clinical trial (Worrilow et al., 2010). Thus, as a 
HBS test, a PCISI technique, a method for selection of hyaluronan bound sperm for use in ICSI, 
has been developed to treat oligozoospermic and asthenozoospermic man infertility problem 
(Parmegiani et al., 2010b). Additionally, recent advanced intracytoplasmic morphologically-
selected sperm injection (IMSI) technique has been used to treat sperm morphology problem 
(teratozoospermia). These techniques have begun to be used in some IVF centers. Thus, some 
detail technologies for sperm selection have been reviewed in chapter 7.  
Finally, the most sever cases of male infertility are those presenting with no sperm in the 
ejaculate (azoospermia). Some men have a condition where their reproductive ducts may be 
absent or blocked (obstructive azoospermia or OA), where others may have no sperm 
production with normal reproductive anatomy (non-obstructive azoospermia or NOA). 
Azoospermia is found in 10% of male infertility cases. Patients with OA due to congenital 
bilateral absence of the vas deferens or those in whom reconstructive surgery fails have 
historically been considered infertile. Men who can not produce sperm in their testes with 
apparent absence of spermatogenesis diagnosed by testicle biopsy are classified as NOA. 
Once testicular and epidiymal function can be verified, surgery is justified to correct or 
remove the blockage. Current optimal method for treatment of azoospermic men is to 
acquire sperm from testicles or epididymides by means of surgery or non-surgery (Wu et 
al., 2005). However, in some situations, no any mature spermatozoon can be obtained from 
either semen or surgical testicular biopsy tissues. Thus immature haploid spermatids or 
diploid spermatocytes or spermatogonia, or even somatic cells like Sertoli cell nuclei or 
Leydig cells may also be considered as a sperm to transfer paternal DNA into maternal 
oocyte to form embryo for transfer. In the chapter of advances in fertility options of 
azoospermic men (Chapter 8), the optimal applications of testicular biopsy sperm, round or 
elongated spermatids from azoospermic men to human IVF have been discussed and some 
new technologies to produce artificial sperm from stem cells and somatic cells as well as 
sperm cloning have been designed. Application of these technologies will make no sperm 
men realize their dream to have a child. 
4. Procedure for embryo transfer  
The procedure of embryo transfer is very crucial and great attention and time should be 
given to this step. The embryo transfer procedure is the last one of the  in vitro fertilization 
process and it is a critically important procedure. No matter how good the IVF laboratory 
culture environment is, the physician can ruin everything with a carelessly performed 
embryo transfer. The entire IVF cycle depends on delicate placement of the embryos at the 
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proper location near the middle of the endometrial cavity with minimal trauma and 
manipulation. The ultimate goal of a successful embryo transfer is to deliver the embryos 
atraumatically to the uterine fundus in a location where implantation is maximized. 
The transfer of embryos can be accomplished in several different fashions including 
transfallopian (ZIFT), transmyometrial and transcervical ways. Today the majority of 
embryo transfers are performed via the cervical canal into the uterine cavity by a specific 
catheter. In order to optimize the embryo transfer technique, although Mansour and 
Aboulghar (2002) had a good review paper about embryo transfer procedure, two chapters 
of this book indicated that several precautions should be taken (Chapter 9 and 10). The first 
and most important is to avoid the initiation of uterine contractility. This can be achieved by 
the use of soft catheters, gentle manipulation and by avoiding touching the fundus. 
Secondly, proper evaluation of the uterine cavity and utero–cervical angulation is very 
important, and this can be achieved by performing dummy embryo transfer and by 
ultrasound evaluation of the utero–cervical angulation and uterine cavity length. Another 
important step is the removal of cervical mucus so that it does not stick to the catheter and 
inadvertently remove the embryo during catheter withdrawal. Finally, one has to be 
absolutely sure that the embryo transfer catheter has passed the internal cervical os and that 
the embryos are delivered gently inside the uterine cavity. 
Embryo stage for transfer also has an important influence on IVF pregnancy outcome. As we 
know, the time and number of transfer embryos have an obvious effect on pregnancy. 
Current IVF technique may make many infertility couple to realize their dream to have 
children, but many treated patients by IVF program have multiple pregnancy problems 
which present a serious perinatal risk for mother and child. This is mainly due to the 
transfer of three or four early cleavage stage embryos. In order to reduce multiple 
pregnancies, the best way is to transfer single embryo. However, this will greatly decrease 
pregnancy rate. Many studies have showed that good quality embryo on morphology will 
have a high chance for implantation, especially good blastocyst stage embryo for transfer. 
Thus, prolonged cultivation of embryos to the blastocyst stage has become a routine practice 
in the human in vitro fertilization program (IVF) since the first commercial sequential media 
were developed in 1999. The advantage of blastocyst culture is able to select the activated 
genome embryos (Braude et al., 1988) which have higher predictive values for implantation on 
the basis of their morphological appearance as compared with earlier embryos (Gardner and 
Schoolcraft, 1999; Kovačič et al., 2004) and in a reduction in the number of transferred embryos 
without compromising pregnancy rate (Gardner et al., 2000). Also transfer of blastocyst stage 
embryos is matching better synchronized with endometrial receptivity for embryo 
implantation. Interestingly, Kovačič et al’s studies (see chapter 11) have showed that single or 
double blastocyst transfer results in similar pregnancy rates in young patient groups, but the 
twin rate remains unacceptably high after the transfer of two blastocysts, especially if at least 
one of them is morphologically optimal. Thus, based on evaluation of blastocyst embryo 
morphology, single embryo transfer is feasible for young couple patients so as to prevent 
multiple pregnancies in IVF program. 
Also, frozen/thawed embryo transfer (FET) has become a routine procedure in all IVF 
centers throughout the world. This treatment involves implanting embryos that were 
retrieved from the patient during a previous IVF cycle and held safely in a frozen state. 
However, FET often results in lower pregnancy rate than fresh embryo transfers. This is 
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because freezing and thawing may damage the morphological characteristics of embryos 
and survival rate of embryo blastomeres resulting into lower implantation rates. Thus, the 
evaluation after embryo thawing and transferring one or several real alive embryos will 
greatly improve pregnancy rate. In chapter 12, a simple research report has showed a 
pregnancy comparison following transfer of cultured versus non cultured frozen thawed 
human embryos. This study provides a feasible method to determine embryo alive after 
embryo thawing by overnight embryo culture to select the embryos with blastomere 
cleavage for transfer. Transferring cleaving embryos after embryo frozen and thawing will 
significantly increase pregnancy rate (Joshi et al., 2010). 
So far, there is still a contradictory whether intercourse is encouraged or not after embryo 
transfer. A large of randomized control trials suggest that intercourse around the time of 
embryo transfer improve embryo implantation rates and increase pregnancy rate, but some 
studies showed no significant difference. Chapter 13 examines the available evidences 
suggesting why intercourse is beneficial or harmful to assisted reproductive technique outcome. 
5. Embryo implantation and endometrial receptivity  
After transfer procedure, embryo will continue growing and finally hatching out from zona 
pellucida to start implantation in the uterus. Thus, implantation is the final frontier to 
embryogenesis and successful pregnancy. Over the past three decades, tremendous 
advances have made in the understanding of human embryo development and its 
implantation in the uterus. Implantation is a process requiring the delicate interaction 
between the embryo and a receptive endometrium. This interactive process is a complex 
series of events that can be divided into three distinct steps: apposition, attachment and 
invasion (Chapter 15, Norwitz et al., 2001). This intricate interaction requires a harmonized 
dialogue between embryonic and maternal tissue. Thus, implantation represents the 
remarkable synchronization between the development of the embryo and the differentiation 
of the endometrium. As long as these events remain unexplained, it is very difficult to 
improve the success of IVF treatment. In last few years, many researches have focused on 
both enhancing the quality of the embryos and understanding the highly dynamic tissue of 
the endometrial wall (Horne et al., 2000) because there is a close relationship between 
endometrial receptivity and embryo implantation. Not only does woman pregnancy depend 
on embryo quality, but also it depends on uterine receptivity because uterine endometrium 
must undergo a serious changes leading to a short time for embryo implantation called the 
“implantation window”. Outside of this time the uterus is resistant to embryo attachment. 
How to determine this window time is very important for obtaining a high pregnancy rate. 
Determining molecular mechanisms of human embryo implantation is an extremely 
challenging task due to the limitation of materials and significant differences underlying this 
process among mammalian species. Recently some papers have reviewed some adhesion 
molecules in endometrial epithelium during tissue integrity and embryo implantation 
(Singh and Aplin, 2009) and the trophinin has been identified as a unique apical cell 
adhesion molecule potentially involved in the initial adhesion of trophectoderm of the 
human blastocyst to endometrial surface epithelia (Fukuda, 2008). In the mouse, the binding 
between ErbB4 on the blastocyst and heparin-binding epidermal growth factor-like growth 
factor on the endometrial surface enables the initial step of the blastocyst implantation. L-
selectin and its ligand carbohydrate have been proposed as a system that mediates initial 
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adhesion of human blastocysts to the uterine epithelia. The evidence suggests that L-selectin 
and trophinin are included in human embryo implantation and their relevant to the 
functions and these cell adhesion mechanisms in human embryo implantation have been 
described (Fukuda, 2008). Interestingly, some important biomarkers including essential 
expression of proteins, cytokines and peptides can be detected in the uterine endometrium 
during embryo implantation (Aghajanova et al., 2008). Also, human cumulus cells may be 
used as biomarkers for embryo and pregnancy outcomes (Assou et al., 2010). Thus, this 
book selected two very interesting papers about mechanism of embryo implantation 
(Chapter 14, and 15). These two articles have explored the mystery of the mechanisms 
controlling the receptivity of the human endometrium. About 20 biomarkers have been 
described and studied to distinguish embryo implantation window time as days 20-24 of 
menstrual cycle. This is very interesting to determine embryo transfer time and to improve 
pregnancy rate. Additionally, screening for receptivity markers and testing patients 
accordingly may allow for increasing use a single embryo transfer.  
From a clinical point of view, the repeated implantation failure is one the least understood 
causes of failure of IVF. The causes for repeated implantation failure may be because of 
reduced endometrial receptivity, embryonic defects or multifactorial causes. Various uterine 
pathologies, such as thin endometrium, altered expression of adhesive molecules and 
immunological factors, may decrease endometrial receptivity, whereas genetic 
abnormalities of the male or female, sperm defects, embryonic aneuploidy or zona 
hardening are among the embryonic reasons for failure of implantation. Endometriosis and 
hydrosalpinges may adversely influence both. Recent advances into the molecular processes 
have delineated possible explanations why the embryos fail to implant. Our selected 
chapters also have a detail description about embryo implantation failure and some feasible 
treatment methods have been recommended.  
6. Fertility cryopreservation 
Fertility cryopreservation is a vital branch of reproductive science and involves the 
preservation of gametes (sperm and oocytes), embryos, and reproductive tissues (ovarian 
and testicular tissues) for use in assisted reproduction techniques. The cryopreservation of 
reproductive cells is the process of freezing, storage, and thawing of spermatozoa or 
oocytes. It involves an initial exposure to cryoprotectants, cooling to subzero temperature, 
storage, thawing, and finally, dilution and removal of the cryoprotectants, when used, with 
a return to a physiological environment that will allow subsequent development. Proper 
management of the osmotic pressure to avoid damage due to intracellular ice formation is 
crucial for successful freezing and thawing procedure. So far there are two major techniques 
for reproductive cell or tissue cryopreservation: slow program frozen-thawing processes 
and vitrification method. Slow program has widely used in many IVF programs for a long 
time and it has been proved to be a feasible practice for human and other animal sperm and 
embryo freezing. In the last decade, many scientists and embryologists are more interested 
in vitrification method because this technique may freeze oocytes and embryos with an 
ultra-fast speed to avoid ice formation within cell during cryopreservation. Thus, it may 
save freezing time and obtain a higher survival rate. In order to understand and apply these 
two methods to human and other animal IVF program, a detail review on reproductive cell 
cryopreservation including sperm, oocyte, embryo and testicular/ovarian biopsy tissues has 
been included in this book (Chapter 16).  
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7. Future use of newly developed embryo transfer technologies 
As our description in introduction section, embryo transfer has experienced three major 
changes, “three generations.” In the human, major application of these techniques focus 
on the second stage where in vitro embryo production is performed by ovum pick up with 
in vitro fertilization (OPU-IVF) for infertile couple treatment. However, the third stage 
including further developed techniques, especially innovated embryo micromanipulation 
techniques, can promote us to perform various embryo manipulation including cloning 
involved somatic cells and embryonic stem cells, preimplantation genetic diagnosis 
(PGD), transgenic animal production etc. As Figure 1 showed, early oocytes may be 
obtained by current in vitro culture of ovarian tissue and primordial germ cells (PGCs), 
because female PGCs may become oogonia, which are mitotically divided several times in 
the ovaries and enter the prophase of first meiosis (Eppig et al., 1989). In the germinal 
vesicle stage (GV), oocyte reconstruction may be conducted by the nuclear transfer 
technique (Takeuchi et al., 1999). In higher organisms including humans, both nucleus 
and mitochondria contain DNA. Mitochondrion is located outside the nucleus in the 
cytoplasm and is an organelle responsible for energy synthesis. Oocyte contains rich 
mitochondria in a large amount of cytoplasm (Spikings et al., 2006). In normal sexual 
reproduction, offspring inherit their mitochondrial DNA from the mother. This type of 
inheritance pattern is generally known as maternal inheritance. When the mother passes 
defective mitochondria to the child, fatal heart, liver, brain or muscular disorders can 
result. In order to prevent this genetic disease, getting rid of mother defective 
mitochondrial DNA, mother nuclear DNA may be transferred into a normal enucleated 
ovum provided a third donor (Figure 2). The purpose of the donation of an enucleated cell 
is to provide the child with non-defective mitochondria, from a woman other than the 
mother. This results in a three-parent embryo. Its nucleus is formed by the fusion of 
sperm and mother's oocyte nucleus, and its cytoplasm is provided by the enucleated 
donor cell. Thus, this child has the inheritance of DNA from three different sources, the 
nuclear DNA is from his father and mother, and his mitochondrial DNA is mainly 
through the donor (Zhang et al., 1999). 
Also, some aged women can not produce normal fertilization eggs and well-development 
embryos. The major problem is that the aged egg lacks synthesizing some components of 
maturation promoter factors, such as cyclin B, c-Mos proto-onco protein, cytostatic factor 
(Wu et al., 1997a, b). Thus, the new developed technique of oocyte (egg) reconstruction 
including nuclear transfer and cytoplasm replace may increase age woman pregnancy 
opportunity. Nuclear transfer is to transfer an age woman nucleus into young woman 
enucleated egg so that aged woman nucleus may complete a normal meiosis (Figure 2). The 
cytoplasm nuclear transfer (Figure 3) may replace partly aged oocyte cytoplasm with 
younger oocyte cytoplasm by transferring part of one woman's egg into another's (Cohen, 
1998). In this case, the healthy portion of a donor egg (the cytoplasm) may supplement the 
defective portion of the infertile recipient's egg and to help it survive, hence making one 
good egg. Thus, the infertile woman's genetic legacy is preserved because the nucleus of this 
egg is made available from the infertile woman and the donor cytoplasm (which simply 
contains mitochondrial DNA that gives the egg energy to survive) contributes only one 
percent of the embryo's genetic makeup. Once the egg is fertilized, the embryo is implanted 
in the infertile woman's uterus. Unfortunately, after many babies were born in the U.S. 
using human cytoplasmic transfer (HCT), ethical and medical complications spurred the 
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U.S. government to curtail the procedure in 2001. Today, fertility scientists must file an 
investigational clinical trial application to continue research in this area, and the New Hope 
Fertility Center in New York intends to obtain approvals and continue our research. It is 
likely that with continued research this technique may prove its efficacy and safety in the 
future. It should be understood that the methods of the present invention are applicable to 
non-human species and, where the law permits, to humans.  
Oocyte Reconstruction
(nuclear transfer)
age woman GV egg
Transfer nucleus 
to young woman 
enucleated oocyte
GVBD MII
young woman GV egg
Meiosis
enucleated
aged woman
partner sperm
Zygote Embryo
 
Fig. 2. Scenario for oocyte reconstruction by nuclear transfer technique. An aged woman 
oocyte nucleus is transferred into a young woman enucleated oocyte so that young woman 
immature oocyte will induce aged woman nucleus to complete meiosis during oocyte 
maturation. Then the aged woman husband sperm will be injected into this reconstructed 
oocyte to form a normal embryo for transfer.  
Further, during oocyte in vitro maturation (IVM) and in vitro fertilization (IVF), some 
techniques such as sperm sexing, oocyte activation, parthenogenesis have been developed 
and applied in animal researches and human infertility treatment. Sex selection is the 
attempt to control the sex of the offspring to achieve a desired sex animal. It can be 
accomplished in several ways, including sperm sex selection and preimplantation embryo 
sex selection. A number of reviews have addressed the use of sexed semen in cattle (Seidel 
and Garner, 2002; Seidel, 2003). The current successful method for separating semen into X- 
or Y-bearing chromosome sperm is to use flow cytometry to sort sperm for artificial 
insemination or IVF (DeJarnette et al. 2007, Blondin et al., 2009). However, in human 
treatment, sex selection seems to have ethical problem. Thus, sperm sexing may be used in  
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Fig. 3. Scenario for oocyte reconstruction by partly cytoplasm replace technique. Firstly 
small amount cytoplasm of aged woman oocyte is removed out and partly young woman 
oocyte cytoplasm will be transferred into this oocyte so that young woman oocyte 
cytoplasm will induce aged woman nucleus to complete meiosis during oocyte maturation. 
Then the aged woman husband sperm will be injected into this reconstructed oocyte to form 
a normal embryo for transfer. 
related x-chromosome disease inherit treatment. One major limitation of sperm sexing is 
low efficient for low sperm motility. Oocyte activation may increase oocyte fertilization or 
result in parthenogenesis. Combining with reliable nuclear transfer method, this oocyte 
activation may produce pathenogenetic bimatermal embryos (Kawahara et al., 2008) or 
andrenogenetic bipaternal embryos (Wu and Zan, 2011, Tesarik 2002). In the chapter 9 of 
this book, the scenario for using immature oocyte to induce male somatic cell complete 
meiosis has been described. The nucleus of immature oocyte is removed and a male diploid 
cell was injected to this enucleated oocyte. After completing meiotic division, the induced 
haploid nucleus was transferred into normal female mature oocyte to form a biparental 
embryo for transfer. Also, a scenario for sperm genome cloning technique is displayed in 
this chapter. A single sperm is injected into enucleated oocyte and this oocyte goes through 
a parthenogenesis process to become a 4-8 cell haploid embryo. A single blastomere is 
transferred into a normal mature oocyte to form a zygote. The developed embryos are 
transferred to recipient mice to deliver offspring. Also, nuclear transfer studies have shown 
that nuclei from not growing oocytes have already been competent to mature into MII stage 
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when transferred into fully grown germinal vesicle-stage oocytes. However, the resultant 
oocytes lack developmental competence, and nuclei from oocytes more than 65 μm in 
diameter first become competent to support term development after fertilization in vitro 
(Niwa et al., 2004). 
After the fertilization, the zygote will be formed and two obvious pronuclei could be 
observed at this stage. The genetic manipulation of the prenuclear stage embryo has 
resulted in two fundamental discoveries in reproductive biology (Wilmut et al., 1991). By 
pronuclear removal and exchanges, the principle of genetic imprinting has been 
convincingly demonstrated. By injecting foreign DNA into one of the two pronuclei of the 
zygote, the resulting offspring may contain a functional foreign gene in the genome, known 
as transgenesis. Production of transgenic animals has great application in agriculture and 
medicine (Niemann and Kues 2003). In agricultural animals, the transgenic technology may 
be applied to develop lines of animals for faster growth, higher quality beef products or 
disease resistance (Greger 2010). Transgenic practices of last decade have proved that by 
inserting a single growth regulating gene into an animal of agricultural value, animal 
growth rate and feed efficiency could be greatly increased and fat deposition could be 
obviously reduced. This technique has been transforming the entire meat animal industry 
(Wheeler, 2007). In human, it is possible to target genetic sequences into predetermined sites 
in the host DNA, to transfer a given gene for some genetic disease therapy. 
Animal cloning may involve embryo cloning and adult somatic cell cloning. During early 
development before 8-cell stage, embryonic cells may be dis-aggregated into individual 
blastomeres. Each blastomere has a totipotency which is able to potentially to develop into a 
viable embryo following nuclear transfer and to regenerate whole new individuals, this is, 
cloning. Also, embryo division is a kind of cloning and it may produce identical twin. In the 
human IVF, one blastomere often is removed from embryo for genetic diagnosis to examine 
some genetic disease and sex determination by fluorescent in situ hybridization (FISH) 
technique or polymerase chain reaction (PCR). The biopsied embryo could develop normal 
fetus and deliver health babies. Also, the process of freezing and thawing can be fairly harsh 
on the embryos and often not all of the cells or embryos survive. After freezing and thawing, 
one or several lysed blastomeres often occur in some embryos and these damaged cells are 
thought to either disrupt the development of the embryo or produce negative factors as they 
degenerate to affect survival blastomere growth. Recently new technique attempts to remove 
these lysed cells from embryo by making a small hole in the zona pellucida with acid or laser. 
The removal of lysed cells will restore the embryo’s developmental potential. Cell number and 
morphology was also significantly improved compared with embryos without lysed cell 
removal (Elliott et al., 2007). This method has been shown to dramatically increase the 
implantation potential of human embryos and pregnancy rate (Nagy et al., 2005).  
Also, many data showed a significant negative correlation between the degree of embryo 
fragmentation and rate of blastocyst development (Eftekhari-Yazdi et al., 2006). As above 
method, this fragmentation of embryo also may be removed. Some studies have indicated 
that the removal of fragmentation from fresh embryo on day 3 may increase the rate of 
blastocyst development (Alikani et al., 1999; Eftekhari-Yazdi et 2006).  
At the blastocyst stage, two distinct cell lines in the embryos may be observed, the inner cell 
mass (ICM) and the trophectoderm (TE) cells. Inner cell mass cells are totipotent stem cells 
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which will give rise to all different tissues in the fetus. By in vitro culturing ICM cells, the 
lines of embryonic stem (ES) cells have been developed. ES cells have the ability to remain 
undifferentiated and proliferate indefinitely in vitro while maintaining the potential to 
differentiate into derivatives of all three embryonic germ layers. Thus, combining cloning 
and nuclear transfer technique, the specific stem cells may be produced from ICM of 
embryos. Recent achievement showed that completely differentiated cells (both fetal and 
adult) may be reprogrammed to return to multipotential embryonic cells, that is the induced 
pluripotent stem cells (iPSCs) with qualities remarkably similar to embryonic stem cells-like 
state by being forced to express genes and factors important for maintaining the defining 
properties of embryonic stem cells (Takahashi and Yamanaka 2006;Yu et al., 2007).This 
discovery has created a valuable new source of pluripotent cells for drug discovery, cell 
therapy, and basic research.  
For more than a decade, preimplantation genetic screening (PGS) and PGD have been used 
to assist in the identification of aneuploid embryos on Day 3. However, current strategies, 
based upon cell biopsy followed by FISH, allow less than half of the chromosomes to be 
screened. Currently, the FISH technique has gradually been replaced by the competitive 
genomic hybridization (CGH) or microarray analysis (Wells, et al., 2008). This analysis can 
evaluate all chromosomes by the trophectoderm biopsies of blastocyst embryos, which may 
significantly reduce embryo harm than Day 3 embryo. Trophectoderm biopsy involves 
removing some cells from the trophectoderm component of an IVF blastocyst embryo. The 
removed cells can be tested for chromosome normality, or for a specific gene defect using 
PGD or preimplantation genetic screening test. Some microarray platforms also offer the 
advantage of embryo fingerprinting and the potential for combined aneuploidy and single 
gene disorder diagnosis. However, more data concerning accuracy and further reductions in 
the price of tests will be necessary before microarrays can be widely applied. 
8. Conclusions 
Not only has embryo transfer already been one of the prominent high businesses worldwide 
for animal breed genetic improvement and creating new animal breeds, but also it has 
become a major tool for the treatment of infertile couples to realize their dream to have their 
children. The new developed embryo biotechnology has been able to make no sperm 
(azoospermia) men realize their dream to have a child. In the meantime, the innovation of 
various technologies, such as ovarian optimal stimulation scheme, new developed ICSI 
techniques, ultra-sound guide embryo transfer, embryo selection, seeking uterus biomarkers, 
have greatly improved transfer embryo pregnancy rates. As new embryo culture method 
improved and PGD, PGS, CGH and microarray analysis techniques developed, a single good 
quality embryo may be chosen for transfer and multiply pregnancies may significantly be 
reduced. Also, embryo cryopreservation technique, especially vitrification, has greatly 
increased embryo survival after thawing and made a single egg retrieval have more 
opportunity for pregnancy. Newly developed technologies such as embryo cloning, nuclear 
transfer, transgenic animals, stem cells etc. have demonstrated great promises for application 
in agricultural and biomedical sciences. Currently, these technologies have been being or will 
be used in human infertility treatment. In the next decade, these technologies will not only 
greatly promote animal genetic improvement and create new animal breeds, but also 
significantly improve human reproductive health.  
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